Dr. Michael Edel
Michael completed his Bachelor of Science (hons) in Anatomy and Human biology and Physiology at the University of Western Australia from 1986 to 2000. He holds a post-graduate diploma in education (computing science) and a PhD in Pathology investigating the role of angiogeneis in metastasis breast cancer.
Dr. Belen Alvarez
Belen completed her PhD in Biochemistry and has extensive experience in the field of cancer research, specifically cancer cell migration and epithelial-mesenchymal transition (EMT). Her post-doctoral work defined a role for Integrin cytoplasmic domain-associated protein-1 (ICAP-1) in promoting migration of myoblasts and affects focal adhesions. Also, she has shown a role for a natural antisense transcript that regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Currently she works on new factors for modified RNA mediated reprograming of somatic cells to iPS cells and differentiation of iPS to oligodendrocyte precursor cells.
Dr. Cristina Menchon
Cristina complete her PhD in 2010 on the role of the cell cycelin human pluripotent cells. She defined a role for the cell cycle inhibitor p27Kip1 in controlling self-renewal and pluripotency of human embryonic stem cells. This work supports a growing body of research suggesting that modification of cell cycle genes regulates the pluripotent state of cells. She currently works on making iPS cell from patient fibroblast for modelling different human diseases.
Jordi Requena Osete
Jordi Requena Osete has a degree in Biology in the University of Girona (2008-2012); he is currently conducting a Biomedical research Master in the University of Barcelona (course 2012-2013) in the Physiology I laboratory (Molecular Genetics Department) in the Hospital Clinic of Barcelona facilities, addressing issues about making high quality mouse iPS cells.
Faculty of Medicine
Department of Biomedicine
Tel. & Fax: 93 403 52 78